Corvus Pharmaceuticals
Price & Volume
Stats
See more52W Range | $1.43-$10 |
Market Cap | $239.9M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.02 |
News
See moreYahoo Finance • 9 days ago
Corvus Pharmaceuticals to Present New Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis on May 8, 2025
Yahoo Finance • 23 days ago
Corvus Pharmaceuticals Appoints Richard A. van den Broek to Board of Directors
About
CEO | Dr. Richard A. Miller M.D. |
Address | 901 Gateway Boulevard, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 31 |
